Key Details
- Meeting of Board of Directors scheduled for Saturday, 11th July, 2026
- Primary agenda: Deliberation upon, consideration and evaluation of issue of securities
- Potential instruments include: equity shares, convertible securities, bonds, debentures
- Potential methods include: preferential issue, rights issue, or any other method or combinations thereof
- Any issuance subject to regulatory/statutory approvals including shareholder approval
Trading Window Status
- Trading window remains closed for all designated persons (including directors) and their immediate relatives
- Closure period: Until completion of 48 hours after declaration of Un-Audited Financial Results (Standalone and Consolidated) for quarter ending 30th June, 2026
Financial Impact
Financial impact not quantified in the disclosure. Any fundraising would be subject to future Board decisions and regulatory approvals.